Apexigen, Inc.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development f…
Biotechnology
US, San Carlos [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Apexigen, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDApexigen, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Apexigen, Inc..
If you want to see a demo, head over to the financial segments of AAPL